監管
Florida AG sues Eli Lilly, Novo Nordisk, Sanofi and three PBMs over insulin pricing
Florida Attorney General James Uthmeier sued insulin makers Eli Lilly, Novo Nordisk and Sanofi, pharmacy benefit managers CVS Caremark, Express Scripts and OptumRx, and rebate aggregators Zinc, Ascent and Emisar in the Eleventh Judicial Circuit. The complaint alleges the manufacturers inflated insulin list prices and paid rebates and fees to the PBMs for preferred formulary placement, and brings claims under Florida's Deceptive and Unfair Trade Practices Act and Antitrust Act.